Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

beta 2 Adrenergic Receptor Antikörper

Der Maus Monoklonal Anti-beta 2 Adrenergic Receptor-Antikörper wurde für EIA, Func und ELISA (Detection) validiert. Er ist geeignet, beta 2 Adrenergic Receptor in Proben von Human, Ratte und Meerschweinchen zu detektieren.
Produktnummer ABIN1105514

Kurzübersicht für beta 2 Adrenergic Receptor Antikörper (ABIN1105514)

Target

Alle beta 2 Adrenergic Receptor (ADRB2) Antikörper anzeigen
beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))

Reaktivität

  • 148
  • 72
  • 72
  • 8
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Ratte, Meerschweinchen

Wirt

  • 154
  • 14
  • 2
  • 1
  • 1
Maus

Klonalität

  • 142
  • 28
  • 2
Monoklonal

Konjugat

  • 88
  • 12
  • 10
  • 10
  • 6
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser beta 2 Adrenergic Receptor Antikörper ist unkonjugiert

Applikation

  • 114
  • 69
  • 55
  • 42
  • 26
  • 26
  • 26
  • 19
  • 18
  • 15
  • 12
  • 7
  • 4
  • 4
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
Enzyme Immunoassay (EIA), Functional Studies (Func), ELISA (Detection)

Klon

6H8
  • Spezifität

    The monoclonal antibody 6H8 recognizes Human beta-2-Adrenoceptor.

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human, Rat, Guinea Pig.

    Aufreinigung

    Protein G

    Immunogen

    Free peptide Beta2-H19C

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2 - 8 °C.
  • Target

    beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))

    Andere Bezeichnung

    beta-2 Adrenergic Receptor

    Hintergrund

    The b -adrenoceptors can be divided into b1, b2, b3 and b4-adrenoceptors defined in terms of agonist potencies, b2-adrenoceptors displayed a higher selectivity for nor-adrenaline than for adrenaline. B2-receptors are mainly postsynaptic and are located on a number of tissues including blood vessels, bronchi, GIT, skeletal muscle, liver and mast cell. Activation results in vasodilatation, bronchodilation, relaxation of the GIT, glycogenolysis in the liver, tremor in skeletal muscle and inhibition of histamine release from mast cells. Transduction is via G-proteins coupled to the intracellular second messenger adenylate cyclase. B-receptors are positively coupled to adenylate cyclase via activation of Gs G-protein, however activation of the b2-adrenoceptors results in stimulation and inhibition of adenylate cyclase. The b2-receptor selective agonists are widely used in the treatment of asthma and other related bronchospastic conditions. They are commonly used in the treatment of angina pectoris, cardiac arrhythmia and for the long-term treatment of patients who survive myocardial infarction. B-receptor antagonists have also been used as anti-hypertensive for a number of years. Beta -blockers have also proven useful in the treatment of conditions such as migraine, anxiety disorders, hyperthyroidism, alcohol withdrawal and when applied topically are useful in the treatment of glaucoma and ocular hypertension.Synonyms: ADRB2, ADRB2R, B2AR, Beta-2 adrenoreceptor

    Gen-ID

    154

    NCBI Accession

    NP_000015

    UniProt

    P07550

    Pathways

    cAMP Metabolic Process, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, Brown Fat Cell Differentiation
Sie sind hier:
Chat with us!